Patient's Query
Hello doctor,
I have plaque psoriasis, and now it has started to involve my joints. The doctor thinks it may be psoriatic arthritis. I am currently using creams, but they do not help much anymore. Should I start biologic therapy? What options are safe and effective for both skin and joint symptoms? Also, are there any oral drugs that work as well as injectables? I am scared of immune suppression.
Kindly help.
Hello,
Welcome to icliniq.com.
I understand your concern.
Based on your description, it does sound like you may be transitioning from plaque psoriasis to psoriatic arthritis, which is not uncommon. Early and appropriate management is key to preventing long-term joint damage and improving your quality of life. While topical treatments (creams and ointments) are effective for localized skin lesions, they are generally insufficient when joint involvement begins.
Psoriatic arthritis requires a systemic approach, targeting both skin and joint inflammation. Biologic therapies are highly effective in treating both the skin and joint symptoms of psoriatic arthritis. They work by targeting specific pathways in the immune system that drive inflammation. Common classes include:
Tumor necrosis factor inhibitors (for example, Adalimumab, Etanercept).
Interleukin 17 inhibitors (for example, Secukinumab, Ixekizumab).
Interleukin 23 inhibitors (for example, Guselkumab, Risankizumab).
Interleukin 12 and interleukin 23 inhibitors (Ustekinumab).
These treatments have shown strong results in reducing both skin plaques and joint pain and swelling. They are generally well tolerated, though, as with any immune-modulating therapy, there is a low risk of infections, which we monitor closely.
There are oral systemic medications available, including:
Apremilast is a phosphodiesterase four inhibitor that has moderate efficacy, a favorable safety profile, and does not cause significant suppression of the immune system.
Methotrexate is often used in mild to moderate cases and is effective for joint symptoms, but it may be less effective for skin symptoms in some people.
Tofacitinib is an oral Janus kinase inhibitor with strong efficacy, but it requires monitoring because it can increase the risk of infections and cause laboratory abnormalities.
Oral options can be convenient, but biologics generally offer superior results, especially when both skin and joints are significantly affected. Your concern about immune suppression is valid. However, most biologics are targeted therapies; they modulate specific immune signals rather than suppressing the entire immune system. With proper screening and monitoring, they can be used safely in the long term.
I recommend discussing these options in detail with your dermatologist and rheumatologist. The right choice will depend on the severity of your symptoms, your overall health, lifestyle preferences, oral versus injectable, and your comfort with potential side effects.
I hope you are satisfied with my answer. For further queries, you can consult me at iCliniq.
Thank you.
Was this conversation helpful?
Answered byDr. Aissa Youcef Mouffoki
Medically reviewed byiCliniq medical review team
Same symptoms don't mean you have the same problem. Consult a doctor now!
Related Questions
Ustekinumab Injection for Plaque Psoriasis: Uses, Administration, Side Effects and Pharmacology
Roflumilast Cream for Plaque Psoriasis - An Insight
Is biologic therapy effective for asthma-COPD overlap?
Does joint pain, night sweats, and dry eyes indicate HIV?
Subtalar Joint Pain - Causes, Diagnosis, and Treatment
Is biologic therapy a long-term treatment for psoriasis?
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.